Solu now offers cgMLST, a second way to compare your samples. Built on community-standard schemes and validated against published studies, it makes results comparable across institutions.

A reproducibility and concordance study validating Solu's cgMLST implementation across seven schemes and eleven bacterial species, showing it recovers epidemiologically verified clusters from published outbreaks and agrees closely with Solu's independent SNP phylogeny.

Whole genome sequencing has become standard in microbiology, but bioinformatics expertise has not. Dr Doug Browning at Aston University is one of the researchers working in that gap, and one of Solu's most active users.

Real-time genomic surveillance prevented 62 infections and saved $695,000 at a single hospital in two years, but those results depend on trustworthy data. Learn how Solu integrates quality control directly into the surveillance pipeline, turning QC flags into actionable next steps in minutes.

Hospitals run genomic surveillance, but the useful information that lives in someone's email or a spreadsheet gets forgotten. We built cluster notes so you can write that context straight into your analyzed data, where everyone on the team can actually find it.

New research showed that 60% of carbapenemase spread happened through plasmids. Yet standard pipelines still fail to scan for horizontal spread. Expect to learn why plasmid-aware surveillance is now more essential than ever for effective genomic surveillance.

Explore Pulse, Solu's integrated plasmid detection feature delivering real-time horizontal transmission surveillance.

Standard genomic surveillance misses plasmids. Solu's platform reconstructs them from raw sequencing data in minutes, revealing lost horizontal transmissions. From hospital sample to genomic insight, expect to learn how Solu helps in turning invisible threats into actionable data for infection control teams.

Horizontal gene transfer accelerates the emergence of drug-resistant infections and reshapes outbreak management. Resistant infections lead to longer hospital stays, higher readmission rates, and rising healthcare costs. Expect to learn more about horizontal spread and how Solu accounts for it in genomic surveillance to prevent epidemics.

Antimicrobial resistance already costs $66B annually, projected to rise to $159B by 2050. Discover why immediate action and strategic investment deliver a 28:1 ROI for healthcare systems.

This blog post leads you through our methodology and answers the questions of how is the analysis and the most complex part, biology, is covered.